Recently, a new pattern of multisystem inflammatory syndrome following an infection with
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has emerged globally. The …

Background: The large-scale utilization of immunoglobulins in patients with inborn errors of
immunity (IEIs) since 1952 prompted the discovery of their key role at high doses as …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has significantly affected the
lives of children in many ways, both directly and indirectly. Although severe acute respiratory …

We conducted an Umbrella review of eligible studies to evaluate what patient features have
been investigated in the multisystem inflammatory syndrome in children (MIS-C) population …

Within 6 months of the coronavirus pandemic, a new disease entity associated with a
multisystem hyperinflammation syndrome as a result of a previous infection with the SARS …

Background The effectiveness of using only glucocorticoids (GCs) in mild multisystem
inflammatory syndrome (MIS-C) cases was compared with combined treatment [GCs+ …

Multisystem inflammatory disease in childhood (MIS-C) is a novel pediatric syndrome after a
COVID-19 infection that causes systemic injury, with potential life-threatening hemodynamic …

With the rapid expansion of the COVID-19 pandemic, the disease burden and its
consequences on the paediatric population has been progressively recognised. Although …

Zusammenfassung Der Begriff Post-COVID-Syndrom (PCS) fasst eine Vielzahl von
Symptomen zusammen, die nach der akuten Phase einer SARS-CoV-2-Infektion vor allem …

Since the beginning of COVID-19 pandemic, a new post-infectious inflammatory
manifestation of SARS-CoV-2 affecting children has been described. It was defined as …